Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2/3 1Phase 2 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neoplasms 1Mental Disorders 1Depression 1Caregiver Burden 1Brain Neoplasms 1

Interventions

Therapeutics 25Psychiatric Rehabilitation 16Cognitive Behavioral Therapy 10Early Intervention, Educational 9Methods 7Yoga 6Mindfulness-Based Cognitive Therapy 6Esketamine 5Educational Status 5Surveys and Questionnaires 4Saline Solution 4Psychosocial Intervention 4Mindfulness 4Interviews as Topic 4Counseling 4Control Groups 4Caregivers 4Behavior Therapy 4Acupuncture Therapy 4Palliative Care 3Meditation 3Hypnosis 3Exercise Therapy 3Transcranial Magnetic Stimulation 2Transcranial Direct Current Stimulation 2Standard of Care 2Self-Help Groups 2Psychotherapy 2Mindfulness-Based Stress Reduction 2Massage 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Depression × Methylphenidate × Clear all
NCT00129467 2015-04-24

Methylphenidate for Depressed Cancer Patients Receiving Palliative Care

VA Office of Research and Development

Phase NA Completed
47 enrolled 13 charts

Caregiver Burden, Mental Disorders, Depression, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡